The Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved. The FDA reviews the IND application for safety to assure that research subjects will not be subjected to unreasonable risk.
See more at Wikipedia.org...
a form submitted by a company as a request for FDAis permission to expose healthy human volunteers to an experimental drug; must be filed for each clinical trial performed, phases 1-3.
Free Download Now!
